Hematometra after radiotherapy for cervical carcinoma

Gynecologic Oncology

Volumn 67, Issue 3, 1997, Pages 325-327

  Vernooij, C B ^a   Kruitwagen, R F P M ^a,b   Rodrigus, P ^b   Kock, H C L V ^b   Feyen, H W H ^b  

^a JEROEN BOSCH HOSPITAL   (Netherlands)

^b Task Force Gynecologic Oncol   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN; PROGESTERONE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CURETTAGE; ESTROGEN THERAPY; FEMALE; HEMATOMETRA; HUMAN; HYSTERECTOMY; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA;

EID: 0031468142     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1997.4883     Document Type: Article

References (10)

1. 1. Aartsen EJ: Fluid detection in the uterus during and after irradiation for carcinoma of the cervix - clinical implications. Eur J Surg Oncol 16:42-46, 1990
2. 2. Piver MS, Rutledge FN, Smith PJ: Five classes of extended hysterectomy of women with cervical cancer. Obstet Gynecol 44:265-272, 1974
3. 3. Höckel M, Schlenger K, Hamm H, Knapstein PG, Hohenfellner R, Rösler HP: Five-year experience with combined operative and radiotherapeutic treatment of recurrent gynecologic tumors infiltrating the pelvic wall. Cancer 77:1918-1933, 1996
4. 4. Larson JE, Whitney CW, Zaino R, Kaminski P, Podczaski E, Mortel R: Endometrial response to endogenous hormones after pelvic irradiation for genital malignancies. Gynecol Oncol 36:106-109, 1990
5. 5. Disaia PJ, Creasman WT: Clinical gynecological oncology. 4th ed, Mosby-Year Book, 1993
6. 6. Barnhill D, Heller P, Dames J, Hoskins W, Gallup D, Park R: Persistence of endometrial activity after radiation therapy for cervical carcinoma. Obstet Gynecol 66:805-808, 1985
7. 7. Gambrell RD, Massey FM, Castaneda TA, Ugenas AJ, Ricci CA, Wright JM: Use of the progestagen challenge test to reduce the risk of endometrial cancer. Obstet Gynecol 55:732-738, 1980
8. 8. Mc Kay MJ, Bull CA, Houghton CR, Langlands AO: Persisting cyclical uterine bleeding in patients treated with radical radiation therapy and hormonal replacement for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 18:921-925, 1990
9. 9. Ginsburg J, Prelevic G, Butler D, Okolo S: Clinical experience with tibolone (Livial) over 8 years. Maturitas 21:71-76, 1995
10. 10. Kwon Th, Prempree T, Tang C, VillaSanta U, Scott RM: Adenocarcinoma of the uterine corpus following irradiation for cervical cancer. Gynecol Oncol 11:102-113, 1981